Adoptive cell transfer of Chimeric Antigen Receptor (CAR)-T cells showed promising results in patients with B cell malignancies. However, the detailed mechanism of CAR-T cell interaction with the target tumor cells is still not well understood. This work provides a systematic method for analyzing the activation and degranulation of second-generation CAR-T cells utilizing antigen-presenting cell surfaces. Antigen-presenting cell surfaces composed of circular micropatterns of CAR-specific anti-idiotype antibodies have been developed to mimic the interaction of CAR-T cells with target tumor cells using micro-contact printing. The levels of activation and degranulation of fixed non-transduced T cells (NT), CD19.CAR-T cells, and GD2.CAR-T cells ...
Chimeric antigen receptors (CARs) usually combine the antigen binding site of a monoclonal antibody ...
Chimeric antigen receptor (CAR) T-cell therapy has been shown to be dramatically effective in the tr...
Chimeric antigen receptor (CAR) T cell immunotherapy is a revolutionary pillar in cancer treatment. ...
Adoptive cell transfer of Chimeric Antigen Receptor (CAR)-T cells showed promising results in patien...
Despite the benefits of chimeric antigen receptor (CAR)–T cell therapies against lymphoid malignanci...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
© 2016 Dr Alexander DavenportDespite the success of autologous chimeric antigen receptor (CAR) T cel...
T cells genetically modified to express a CD19-specific chimeric antigen receptor (CAR) for the inve...
Background: It remains challenging to characterize the functional attributes of chimeric antigen re...
A major obstacle for chimeric antigen receptor (CAR) T cell therapy in solid tumors is the lack of t...
While the clinical progress of chimeric antigen receptor T cell (CAR-T) immunotherapy has garnered a...
CAR-T cell therapy has emerged as a promising cancer treatment modality with curative potential. In ...
Investigators developed chimeric antigen receptors (CARs) for expression on T cells more than 25 yea...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
Chimeric antigen receptors (CARs) usually combine the antigen binding site of a monoclonal antibody ...
Chimeric antigen receptor (CAR) T-cell therapy has been shown to be dramatically effective in the tr...
Chimeric antigen receptor (CAR) T cell immunotherapy is a revolutionary pillar in cancer treatment. ...
Adoptive cell transfer of Chimeric Antigen Receptor (CAR)-T cells showed promising results in patien...
Despite the benefits of chimeric antigen receptor (CAR)–T cell therapies against lymphoid malignanci...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
© 2016 Dr Alexander DavenportDespite the success of autologous chimeric antigen receptor (CAR) T cel...
T cells genetically modified to express a CD19-specific chimeric antigen receptor (CAR) for the inve...
Background: It remains challenging to characterize the functional attributes of chimeric antigen re...
A major obstacle for chimeric antigen receptor (CAR) T cell therapy in solid tumors is the lack of t...
While the clinical progress of chimeric antigen receptor T cell (CAR-T) immunotherapy has garnered a...
CAR-T cell therapy has emerged as a promising cancer treatment modality with curative potential. In ...
Investigators developed chimeric antigen receptors (CARs) for expression on T cells more than 25 yea...
BackgroundT cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer...
Chimeric antigen receptors (CARs) usually combine the antigen binding site of a monoclonal antibody ...
Chimeric antigen receptor (CAR) T-cell therapy has been shown to be dramatically effective in the tr...
Chimeric antigen receptor (CAR) T cell immunotherapy is a revolutionary pillar in cancer treatment. ...